Adage Capital Advisors, L.L.C.
CIK 1403403 · last filed 2023-05-05
Adage Capital Advisors, L.L.C. is a corporate insider who has filed 20 SEC Form 4 insider transactions across 13 companies since 2008. The most recent filing shows the insider sold $12.3M of GCMGW on May 5, 2023. Across all open-market trades the lifetime net is −$2.09B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.53B across reported positions. The firm reports its address in Boston, MA. 127 SEC filings were submitted jointly with Robert Atchinson.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.53B
13
20
-$2.09B
Filer Profile
52ND FLOOR
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GCM Grosvenor Inc. (GCMGW) Delisted | 10%+ Owner | 4,526,021 | $0.01 | $43.0K | -$46.46M | 2 | 2023-05-05 |
| Abacus Global Management, Inc. (ERESW) Delisted | 10%+ Owner | 0 | $0.28 | $0 | $0 | 1 | 2023-01-24 |
| RPRX | 10%+ Owner | 38,714,280 | $63.96 | $2.48B | -$1.60B | 1 | 2020-12-18 |
| ADVENT TECHNOLOGIES HOLDINGS, INC. (AMCIW) Delisted | 10%+ Owner | 1,350,000 | $0.33 | $445.6K | -$61.44M | 1 | 2020-12-03 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | 10%+ Owner | 4,100,043 | — | — | -$12.90M | 1 | 2017-10-12 |
| PBYI | 10%+ Owner | 5,491,653 | $9.55 | $52.45M | -$400.82M | 4 | 2017-05-26 |
| Calithera Biosciences, Inc. (CALA) Delisted | 10%+ Owner | 181,753 | $0.00 | $55 | $7.88M | 1 | 2016-11-17 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | 10%+ Owner | 5,139,366 | — | — | $25.68M | 1 | 2015-02-20 |
| Nexvet Biopharma plc (NVET) Delisted | 10%+ Owner | 875,000 | — | — | $13.75M | 1 | 2015-02-10 |
| BOULDER BRANDS, INC. (SMBL) Delisted | 10%+ Owner | 6,563,680 | — | — | -$14.02M | 1 | 2013-01-02 |
| Sleep Number Corp (SCSS) Delisted | 10%+ Owner | 5,778,000 | — | — | -$16.28M | 1 | 2011-02-08 |
| Cardiome Pharma Corp (CRME) Delisted | 10%+ Owner | 7,850,000 | — | — | $19.60M | 1 | 2009-04-13 |
| HUBBELL INC (HUB.B) Delisted | 724,000 | — | — | -$742.5K | 1 | 2008-04-28 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-05 | GCM Grosvenor Inc. (GCMGW) Delisted | Sell (S) | −1,576,120 | -$12.35M | EDGAR |
| 2023-01-24 | Abacus Global Management, Inc. (ERESW) Delisted | Other (J) | −11,741,070 | -$119.88M | EDGAR |
| 2021-07-13 | GCM Grosvenor Inc. (GCMGW) Delisted | Mixed | −2,586,270 | -$34.11M | EDGAR |
| 2020-12-18 | RPRX | Sell (S) | −36,505,250 | -$1.60B | EDGAR |
| 2020-12-03 | ADVENT TECHNOLOGIES HOLDINGS, INC. (AMCIW) Delisted | Sell (S) | −5,092,325 | -$61.44M | EDGAR |
| 2019-11-22 | — | Sell (S) | −670,005 | -$2.70M | |
| 2017-10-12 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Sell (S) | −3,000,000 | -$12.90M | EDGAR |
| 2017-05-26 | PBYI | Sell (S) | −6,178,500 | -$465.72M | EDGAR |
| 2016-11-17 | Calithera Biosciences, Inc. (CALA) Delisted | Buy (P) | +2,500,000 | $7.88M | EDGAR |
| 2015-02-20 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Buy (P) | +3,423,810 | $25.68M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.